Abstract:e14667 Background: MicroRNAs (miRNAs) are small, non-coding RNAs that are strongly implicated in cancer and reshaped our understanding of the role of non-protein-coding genes in carcinogenesis. Methods: Quantitative RT-PCR was used to evaluate miR-202-3p expression in 94 pairs of human primary CRC and adjacent noncancerous tissues (NCT) to determine the clinicopathologic significance of miR-202-3p. Cell proliferation analysis and Xenograft analysis was used to investigate miR-202-3p function in vitro and in vivo.It’s direct target ARL5A was confirmed by Luciferase assay and Western blot. Immunochemistry was performed to reveal endogenous protein level of ARL5A and analysis clinical significance. Results: In this study, miR-202-3p was verified significantly down regulated in 46.7% (44/94) of the CRC tissues when compared to the corresponding noncancerous tissues(NCT). Subsequently, DNA copy number deletion of Pre-miR-202 in 63.2%(24/38) CRC tissue was proved(compared with NCT), which was considered as a main cause of the low expression of miR-202-3p. Cell proliferation analysis and colony formation assay showed that overexpression of miR-202-3p inhibit CRC cell growth in vitro. Xenograft analysis revealed that ectopic expression of miR-202-3p decreased the tumorigenicity of CRC cells in vivo. Consistent with these results, silencing of miR-202-3p resulted in a increased growth ratio of the colon cancer cells. In addition, ADP-ribosylation factor-like 5A(ARL5A) was predicted as potential target of miR-202-3p which was confirmed by Luciferase assay and Western blot. Overexpression of miR-202-3p could reduced the endogenous protein level of ARL5A, whereas silencing of miR-202-3p obviously up regulated ARL5A expression. In human CRC tissues, miR-202-3p expression levels correlated inversely with ARL5A protein levels which was identified as an prognostic factor in this study. Furthermore, knockdown of ARL5A phenocopied the proliferation-inhibiting effect of miR-202-3p. Conclusions: These results indicated that miR-202-3p, acting as a new tumor suppressor in CRC, could decrease cell proliferation via directly targeting ARL5A, a first reported gene related to CRC prognosis.

Microrna-205 Functions As A Tumor Suppressor in Colorectal Cancer by Targeting Camp Responsive Element Binding Protein 1 (Creb1)

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

Mir-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A.

MiRNA-203 Suppresses Cell Proliferation, Migration and Invasion in Colorectal Cancer Via Targeting of EIF5A2

Biology of Human Tumors miR-2045 p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB 22 A

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

MicroRNA‐383 Acts As a Tumor Suppressor in Colorectal Cancer by Modulating CREPT/RPRD1B Expression

Microrna-187 Inhibits Tumor Growth and Invasion by Directly Targeting Cd276 in Colorectal Cancer

A CREB 1 / Mir-433 Reciprocal Feedback Loop Modulates Proliferation and Metastasis in Colorectal Cancer

Microrna‐219‐5p Inhibits Epithelial‐mesenchymal Transition and Metastasis of Colorectal Cancer by Targeting Lymphoid Enhancer‐binding Factor 1

MicroRNA-155 acts as a tumor suppressor in colorectal cancer by targeting CTHRC1 in vitro.

MicroRNA-378-5p Suppresses Cell Proliferation and Induces Apoptosis in Colorectal Cancer Cells by Targeting BRAF

MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer

Downregulation of miR-654-3p in Colorectal Cancer Indicates Poor Prognosis and Promotes Cell Proliferation and Invasion by Targeting SRC

Microrna-485-5p Functions As a Tumor Suppressor in Colorectal Cancer Cells by Targeting CD147

Effect of Microrna-202-3p on Cell Proliferation and Targeting of ADP-ribosylation Factor-Like 5A in Human Colorectal Carcinoma.

Mir-150-5p Suppresses Tumor Progression by Targeting VEGFA in Colorectal Cancer

Mir-191 Promotes Tumorigenesis of Human Colorectal Cancer Through Targeting C/EBPβ.

miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.

Suppression of cell growth and invasion by miR-205 in breast cancer

Mir-193B Directly Targets STMN1 and Inhibits the Malignant Phenotype in Colorectal Cancer.